Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

類似資料

• Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial
  著者:: Fava, Maurizio, 等
  出版事項: (2018)
• Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial
  著者:: Yatham, Lakshmi N., 等
  出版事項: (2020)
• Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study
  著者:: Earley, Willie R., 等
  出版事項: (2019)
• SU14. Characteristics Associated With Relapse in Patients With Schizophrenia: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Cariprazine Relapse Prevention Trial
  著者:: Kunovac, Jelena, 等
  出版事項: (2017)
• Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder
  著者:: Vieta, Eduard, 等
  出版事項: (2019)